BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29193203)

  • 1. Nuclear and cytoplasmic features in the diagnosis of Clark's nevi.
    Valdebran M; Bandino J; Elbendary A; Gad A; Arudra KC; de Feraudy S; Elston DM
    J Cutan Pathol; 2018 Mar; 45(3):204-207. PubMed ID: 29193203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clark's nevus.
    Metcalf JS; Maize JC
    Semin Cutan Med Surg; 1999 Mar; 18(1):43-6. PubMed ID: 10188841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear and cytoplasmic features in the diagnosis of banal nevi, Spitz nevi, and melanoma.
    Valdebran M; Elbendary A; Chaitanya Arudra SK; Torres KM; Elattar I; Elston DM
    J Am Acad Dermatol; 2016 Nov; 75(5):1032-1037.e8. PubMed ID: 27542585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanocytic nevi with features of Spitz nevi and Clark's/dysplastic nevi ("Spark's" nevi).
    Ko CJ; McNiff JM; Glusac EJ
    J Cutan Pathol; 2009 Oct; 36(10):1063-8. PubMed ID: 19187111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Clark's nevus.
    Marchesi L; Naldi L; Locati F; Tribbia G; Pezzica E; Parma A; Cainelli T
    Am J Dermatopathol; 1994 Aug; 16(4):364-71. PubMed ID: 7978065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity, specificity, and diagnostic accuracy of three dermoscopic algorithmic methods in the diagnosis of doubtful melanocytic lesions: the importance of light brown structureless areas in differentiating atypical melanocytic nevi from thin melanomas.
    Annessi G; Bono R; Sampogna F; Faraggiana T; Abeni D
    J Am Acad Dermatol; 2007 May; 56(5):759-67. PubMed ID: 17316894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of cytoplasmic phosphorylated CSE1L in malignant melanoma but not in benign nevi: phosphorylated CSE1L for the discrimination between melanoma and benign nevi.
    Chin SY; Wu PR; Shih YH; Yeh CM; Lee WR; Shen SC; Yeh KT; Jiang MC; Tseng JT
    Int J Clin Exp Pathol; 2015; 8(2):1393-401. PubMed ID: 25973023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of histologic architectural and cytoplasmic features with nuclear atypia in atypical (dysplastic) nevomelanocytic nevi.
    Barnhill RL; Roush GC; Duray PH
    Hum Pathol; 1990 Jan; 21(1):51-8. PubMed ID: 2295508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epiluminescence microscopic characteristics of small malignant melanoma].
    Schulz H
    Hautarzt; 1997 Dec; 48(12):904-9. PubMed ID: 9486362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new look at nevus-associated melanomas.
    Harley S; Walsh N
    Am J Dermatopathol; 1996 Apr; 18(2):137-41. PubMed ID: 8739987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear expression of the antiapoptotic protein survivin in malignant melanoma.
    Ding Y; Prieto VG; Zhang PS; Rosenthal S; Smith KJ; Skelton HG; Diwan AH
    Cancer; 2006 Mar; 106(5):1123-9. PubMed ID: 16456815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating clinical/dermatoscopic findings and fluorescence in situ hybridization in diagnosing melanocytic neoplasms with less than definitive histopathologic features.
    Nardone B; Martini M; Busam K; Marghoob A; West DP; Gerami P
    J Am Acad Dermatol; 2012 Jun; 66(6):917-22. PubMed ID: 21962759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
    Fullen DR; Zhu W; Thomas D; Su LD
    J Cutan Pathol; 2005 Nov; 32(10):680-4. PubMed ID: 16293180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Unusual and unknown aspect of cutaneous malignant melanoma: minimal deviation malignant melanoma. Retrospective study of 45 cases].
    Mérot Y; Mihm MC
    Ann Dermatol Venereol; 1985; 112(4):325-36. PubMed ID: 4026131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common acquired melanocytic nevi, melanocytic dysplasia and malignant melanoma. A morphometric study.
    Santucci M; Urso C; Giannini A; Bondi R
    Appl Pathol; 1989; 7(2):111-5. PubMed ID: 2730799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD31 and CD34 expression as immunohistochemical markers of endothelial transdifferentiation in human cutaneous melanoma.
    Pisacane AM; Picciotto F; Risio M
    Cell Oncol; 2007; 29(1):59-66. PubMed ID: 17429142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysplastic nevi.
    Farber MJ; Heilman ER; Friedman RJ
    Dermatol Clin; 2012 Jul; 30(3):389-404. PubMed ID: 22800547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of dermoscopy and reflectance confocal microscopy for distinguishing melanomas from nevi of the breast area.
    Mandel VD; Bombonato C; Pampena R; Kyrgidis A; Borsari S; Benati E; Mirra M; Piana S; Pellacani G; Longo C
    J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):940-946. PubMed ID: 29125708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleolar organizer regions argyrophilic associated proteins in cutaneous melanocytic lesions.
    Reis JP; Tellechea O; Baptista AP
    Dermatologica; 1991; 183(2):136-8. PubMed ID: 1743375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermoscopy of a Spark's nevus.
    Biondo G; Gnone M; Sola S; Pastorino C; Massone C
    Dermatol Pract Concept; 2018 Apr; 8(2):126-128. PubMed ID: 29785330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.